MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, ...
In a report released today, Mark Mahaney from Evercore ISI maintained a Buy rating on Integral Ad Science (IAS – Research Report), with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback